New Agents for the Treatment of Hepatitis C Virus &Ndash; Focus on Telaprevir

Virus Adaptation and Treatment - New Zealand
doi 10.2147/vaat.s12707
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Focus on the Elimination of Hepatitis C Virus

Remedium Journal about the Russian market of medicines and medical equipment
2018English

Benefit–risk Assessment of New and Emerging Treatments for Hepatitis C: Focus on Simeprevir and Sofosbuvir

Drug, Healthcare and Patient Safety
Health PolicyPharmacology
2014English

Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment With Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C: Safety Management in Clinical Practice

Liver International
Hepatology
2011English

Hepatitis C Virus Treatment Update

Sohag Medical Journal
2019English

The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients

2015English

Treatment Options for Chronic Hepatitis C Virus Infection

Medicinski Pregled
Medicine
2006English

The Cost of Treatment of the New Antiviral Therapies Against the Hepatitis C Virus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy